Delaware regulator highlights carriers possibly overextending step therapy exceptions for biologics
Delaware’s insurance regulator is stepping in to clarify rules around step therapy exceptions, especially when it comes to biologic drugs. On March 24, 2026, the Delaware Department of Insurance issued a bulletin aimed at all insurers and health plans regulated under the state law. The notice highlights concerns that some carriers might be stretching exceptions … Read more